SAR228810
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR228810, covering 2015-03-25 to 2015-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients [Phase 1]